BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 14, 2003
View Archived Issues
Epimmune Plans Acquisition Of Anosys For Synergistic Platform
The San Diego-based company entered a preliminary merger agreement with Anosys Inc. to create a combined entity focused on immunotherapeutics and products to treat cancer and infectious diseases. (BioWorld Today)
Read More
RAC Says Stopping Trials With Retroviral Vectors Not Warranted
Read More
Trans-Atlantic Genomic Search For Leprosy Susceptibility Gene Heats Up Over Chromosomal Candidates
Read More
Albany Molecular Expands Via Lilly Deal, Organichem Purchase
Read More
Holiday Notice
Read More
Correction
Read More
Other News To Note
Read More